title: Specific binding and characteristics of 18β-glycyrrhetinic acid in rat brain.
abstract: 18β-Glycyrrhetinic acid (GA) is the aglycone of glycyrrhizin that is a component of Glycyrrhiza, and has several pharmacological actions in the central nervous system. Recently, GA has been demonstrated to reach the brain by crossing the blood-brain barrier in rats after oral administration of a Glycyrrhiza-containing traditional Japanese medicine, yokukansan. These findings suggest that there are specific binding sites for GA in the brain. Here we show evidence that [3H]GA binds specifically to several brain areas by quantitative autoradiography; the density was higher in the hippocampus, moderate in the caudate putamen, nucleus accumbens, amygdala, olfactory bulb, cerebral cortex, thalamus, and mid brain, and lower in the brain stem and cerebellum. Several kinds of steroids, gap junction-blocking reagents, glutamate transporter-recognized compounds, and glutamate receptor agonists did not inhibit the [3H]GA binding. Microautoradiography showed that the [3H]GA signals in the hippocampus were distributed in small non-neuronal cells similar to astrocytes. Immunohistochemical analysis revealed that immunoreactivity of 11β-hydroxysteroid dehydrogenase type-1 (11β-HSD1), a defined molecule recognized by GA, was detected mainly in neurons, moderately in astrocytes, and very slightly in microglial cells, of the hippocampus. These results demonstrate that specific binding sites for GA exist in rat brain tissue, and suggest that the pharmacological actions of GA may be related to 11β-HSD1 in astrocytes. This finding provides important information to understand the pharmacology of GA in the brain.
authors.affiliation: Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, Japan.
authors.forename: Kazushige
authors.initials: K
authors.lastname: Mizoguchi
authors.affiliation: Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, Japan.
authors.forename: Hitomi
authors.initials: H
authors.lastname: Kanno
authors.affiliation: Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, Japan.
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Ikarashi
authors.affiliation: Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki, Japan.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kase
mesh_terms: D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1 / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001345:Autoradiography; D001921:Brain / Q000378:metabolism*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism*; D007150:Immunohistochemistry; D017628:Microglia / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D051381:Rats
chemical_list: C119129:18alpha-glycyrrhetinic acid; D043205:11-beta-Hydroxysteroid Dehydrogenase Type 1; D006034:Glycyrrhetinic Acid
references.citation: Biochim Biophys Acta. 1992 Nov 20;1160(2):229-34
references.pmid: 1445950
references.citation: Neuroscience. 2012 Apr 5;207:124-36
references.pmid: 22314317
references.citation: PLoS One. 2011;6(6):e21108
references.pmid: 21712989
references.citation: Pharmacology. 2006;76(1):19-33
references.pmid: 16224201
references.citation: Phytother Res. 2008 Jun;22(6):709-24
references.pmid: 18446848
references.citation: Biol Pharm Bull. 2009 Oct;32(10):1701-9
references.pmid: 19801831
references.citation: Hum Psychopharmacol. 2013 Jan;28(1):80-6
references.pmid: 23359469
references.citation: Nutr Neurosci. 2008 Feb;11(1):41-6
references.pmid: 18510802
references.citation: Prog Neurobiol. 2011 Mar;93(3):421-43
references.pmid: 21219963
references.citation: J Neurosci. 2012 Nov 14;32(46):16129-40
references.pmid: 23152597
references.citation: Bioorg Med Chem. 2007 Aug 15;15(16):5432-9
references.pmid: 17566745
references.citation: Trends Cell Biol. 2010 Feb;20(2):92-101
references.pmid: 19944606
references.citation: Exp Neurol. 2008 Nov;214(1):144-6
references.pmid: 18775425
references.citation: Front Neuroendocrinol. 1997 Jan;18(1):49-99
references.pmid: 9000459
references.citation: Endocrinology. 1975 Jul;97(1):46-51
references.pmid: 166832
references.citation: Eur J Pharmacol. 2010 Jan 25;626(2-3):154-8
references.pmid: 19818347
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):308-11
references.pmid: 19138715
references.citation: Cell Mol Neurobiol. 2011 Nov;31(8):1203-12
references.pmid: 21691759
references.citation: Tohoku J Exp Med. 2009 Feb;217(2):87-92
references.pmid: 19212100
references.citation: Nature. 2007 Jan 11;445(7124):168-76
references.pmid: 17151600
references.citation: Nat Med. 2013 Jun;19(6):773-7
references.pmid: 23644515
references.citation: J Pharm Pharmacol. 1996 Sep;48(9):902-5
references.pmid: 8910850
references.citation: Schizophr Bull. 2014 Jul;40(4):925-35
references.pmid: 23956119
references.citation: Neuron. 2004 Apr 22;42(2):253-68
references.pmid: 15091341
references.citation: Neuroscience. 2011 Mar 17;177:127-37
references.pmid: 21195139
references.citation: J Membr Biol. 2002 Jan 15;185(2):93-102
references.pmid: 11891568
references.citation: Biochim Biophys Acta. 1991 Jul 1;1066(1):77-82
references.pmid: 2065071
references.citation: J Clin Psychiatry. 2005 Feb;66(2):248-52
references.pmid: 15705012
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):541-5
references.pmid: 20184936
references.citation: Neuroscience. 2011 Apr 28;180:305-13
references.pmid: 21303686
references.citation: Mech Ageing Dev. 2007 Apr;128(4):311-6
references.pmid: 17350671
references.citation: Am J Physiol Cell Physiol. 2008 Sep;295(3):C761-7
references.pmid: 18596212
references.citation: Biochem Biophys Res Commun. 1986 Jan 14;134(1):29-36
references.pmid: 3947327
references.citation: Aging Cell. 2011 Jun;10(3):466-82
references.pmid: 21385309
references.citation: Neuron. 1994 Sep;13(3):713-25
references.pmid: 7917301
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50
references.pmid: 12721370
references.citation: Neurobiol Aging. 2010 Apr;31(4):578-90
references.pmid: 18586353
references.citation: Trends Neurosci. 2005 Apr;28(4):188-95
references.pmid: 15808353
references.citation: Mol Endocrinol. 1989 Nov;3(11):1886-94
references.pmid: 2558306
references.citation: Eur J Neurosci. 2006 Jan;23(2):489-96
references.pmid: 16420455
references.citation: J Neurosci. 2011 Mar 30;31(13):4962-77
references.pmid: 21451035
references.citation: Brain Res Mol Brain Res. 1992 Apr;13(3):199-206
references.pmid: 1317493
references.citation: Brain Res Bull. 2009 Oct 28;80(4-5):196-202
references.pmid: 19559767
references.citation: J Neurosci. 1997 Nov 1;17(21):8363-75
references.pmid: 9334410
references.citation: Cell Mol Neurobiol. 2012 Oct;32(7):1139-46
references.pmid: 22488528